The Connecticut-based payer is labeling peripheral nerve stimulation, used to treat chronic pain, as medically unnecessary, with the Society of Interventional Radiology and others questioning the rationale.
The January employment situation summary, released Feb. 11 by the Bureau of Labor Statistics, shows an American economy leaning heavily on healthcare to put jobseekers to work.
Members of Congress caution that the fee could be especially consequential for rural and urban safety net hospitals, which could be pushed “to their financial brink” if they are required to absorb the charge.
Around a third of teens between 13 and 17 years old are involved with sexting—either as senders, receivers or both. Among the senders, around half become victims of unwanted re-sharing.
Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.
Experts believe the imaging agent "has the potential to meaningfully advance early diagnosis, change the treatment paradigm and improve patient outcomes."
New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.
